Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT
Background: VITT has emerged as a rare but serious adverse event linked primarily to adenoviral vector COVID-19 vaccinations, such as ChAdOx1-S (Oxford/AstraZeneca) vaccination. The syndrome is characterized by thrombosis with thrombocytopenia, elevated D-dimer, and pathologic platelet factor 4 anti...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-01-01
|
| Serie: | Research and Practice in Thrombosis and Haemostasis |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2475037925000019 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
